Page 19 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

Designed to promote the prevention and early intervention of hypertension, hyperlipidaemia,
hyperglycaemia in an increasingly high-risk but currently underserved population (targeted
age group: 45 to 54 years), we conclude that the Scheme is particularly novel and innovative
against a backdrop of a myriad of PPPs in Hong Kong. The Scheme stands out as a
promising programme in consideration of its targeted design with a strong focus on prevention,
wherein all eligible individuals within the targeted demographic can join. Additionally, its
design as a hybrid (both demand-side and supply-side financing) purchasing model that
draws upon the analysis of limitations in existing PPPs will ensure that the care provided is
holistic, facilitates continuity of care, and are of high transparency, quality, and accountability.
Finally, the Scheme is positioned in line with the latest government policy agenda and
initiatives in PHC development. Our demonstration illustrates how applying strategic
purchasing at a systems level can potentially contribute to significant cost savings for the
health system and ultimately, promote system sustainability.

As the Government continues its momentum in building a solid primary care ecosystem for
Hong Kong, relevant authorities need to consider how the proposed Scheme can be
implemented. Importantly, the Government needs to consider the adoption of health system
strategic purchasing in tackling key health system gaps, combatting health system
inefficiencies and achieving a person-centred integrated care system that is necessary for
Hong Kong’s health system to become fit-for-purpose.

17